Loading organizations...

§ Private Profile · ul. Vetterów 1, Lublin, Poland
Sundose is a technology company.
Sundose develops personalized dietary supplements, offering customized nutritional mixes tailored to individual needs. The company utilizes a data-driven approach to blend essential vitamins, minerals, and other compounds into unique formulations, delivered as convenient single daily doses. This method aims to optimize nutritional intake by moving beyond generic supplementation, focusing instead on precise, individual biological requirements.
The company was established in 2018 by co-founders Piotr Smolen, Michal Golkiewicz, and Tomasz Styk. Their foundational insight stemmed from the understanding that nutritional requirements vary significantly among individuals, prompting the need for highly specific dietary support. This realization drove them to create a system that could accurately assess and then supply personalized supplement blends, departing from traditional, one-size-fits-all health solutions.
Sundose serves individuals seeking bespoke nutritional solutions to support their overall health and wellness goals. The company’s vision centers on empowering customers with unique supplement formulations that are meticulously adapted to their specific physiological profiles. It aims to redefine daily supplementation by making it entirely personal, fostering optimal well-being through scientific, individualized nutritional support.
Sundose has raised $7.0M across 2 funding rounds.
Sundose has raised $7.0M in total across 2 funding rounds.
Sundose has raised $7.0M across 2 funding rounds. Most recently, it raised $6.0M Series A in April 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2021 | $6M Series A | DX Ventures, Atmos Ventures | Aria, Investible, Polipo Ventures | Announced |
| Mar 1, 2020 | $1M Seed | — | — | Announced |
Sundose has raised $7.0M in total across 2 funding rounds.
Sundose's investors include DX Ventures, Atmos Ventures, ARIA, Investible, Polipo Ventures.
# Sundose: A Technology-Driven Personalization Platform
Sundose is a direct-to-consumer (D2C) e-commerce platform that uses data and algorithms to create personalized dietary supplements tailored to individual health profiles.[1][2] Founded in 2016 (with product development beginning in 2018), the company addresses a fundamental gap in the supplement industry: the one-size-fits-all approach to nutrition.[2] Rather than selling generic vitamins, Sundose gathers health data through medical questionnaires, blood test results, and consultations with clinical nutritionists to formulate custom supplement blends delivered monthly to customers' doorsteps.[2][3]
The company has achieved meaningful traction, serving approximately 10,000 customers per month with annual revenue around PLN 10–12 million (roughly USD 2.5–3 million).[1] Currently operating primarily in Poland, Sundose has expanded into the UK, Germany, and Italy, with plans for broader international growth following a USD 6 million funding round led by Aria Fund alongside Atmos Ventures, DX Ventures, Investible, and Polipo Ventures.[1]
Sundose emerged from the vision of co-founders Michał Gołkiewicz and Tomasz Styk, who began developing a business model centered on customized dietary supplements around 2016.[2] The founders recognized that personalization in supplement selection was virtually nonexistent, even in Western European markets, presenting a significant opportunity for innovation.[1] Early validation came through institutional investment in 2019 when KnowledgeHub Starter backed the company, followed by product expansion and the introduction of a flexible "Pay Per Use" pricing model that adjusts costs based on the customer's chosen composition.[2]
The company's evolution reflects a deliberate focus on solving a real problem: most consumers receive generic supplement recommendations despite having vastly different health needs, genetics, and lifestyles. This insight drove the development of Sundose's core technology stack.
Sundose operates at the intersection of health tech, e-commerce, and data analytics—three of the most dynamic sectors in European tech. The company exemplifies a broader trend: the shift from reactive, one-size-fits-all healthcare products toward proactive, data-driven personalization. This aligns with growing consumer demand for precision nutrition and preventive health solutions, particularly among digitally native audiences willing to share health data in exchange for tailored outcomes.
The timing is particularly favorable. Regulatory frameworks around health data are maturing, consumer acceptance of digital health tools is accelerating, and manufacturing technology now enables economical production of custom formulations at scale. Sundose's success validates that personalization in supplements—long considered a niche concept—is becoming mainstream, even in conservative Western European markets.[1]
The company also demonstrates how European startups can compete globally by solving hyperlocal problems first (Poland's supplement market) before expanding internationally. This approach reduces execution risk while building defensible data advantages.
Sundose is positioned to become a category leader in personalized nutrition, with several growth vectors ahead. The company's stated priorities—expanding the personalization engine to incorporate advanced medical diagnostics, developing mobile-first interfaces, and entering new geographic markets—suggest ambitions to become the operating system for individualized supplementation.[1]
The critical question is whether Sundose can scale its data advantage faster than competitors. As the personalization engine matures and the company accumulates health data across thousands of users, the algorithmic recommendations should improve exponentially, creating a moat that generic supplement companies cannot easily replicate. International expansion will test whether the personalization model translates across different health systems, regulatory environments, and consumer preferences.
If Sundose successfully executes its roadmap, it could reshape how consumers think about supplementation—moving from "What should I take?" to "What should *I* take, specifically?" That shift from generic to personalized represents a fundamental reimagining of the supplement category, with significant market implications.